Christopher E Rudd

11PUBLICATIONS

7CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Reaction engineering (excl. nuclear reactions)Colloid and surface chemistryPredictive and prognostic markersSocial program evaluation

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|May 19, 2026

GSK-3 regulates CD4-CD8 cooperation for super-armed CD8+ cytolytic T cells in immunotherapy against tumors.

|Apr 02, 2025

Comment on: Glycogen synthase kinase 3 controls T-cell exhaustion by regulating NFAT activation.

Bastien Moës, Christopher E Rudd

|Jan 06, 2025

The identification of a SARs-CoV2 S2 protein derived peptide with super-antigen-like stimulatory properties on T-cells.

Thai Hien Tu, Fatima Ezzahra Bennani, Nasser Masroori

|May 03, 2024

Decreased progenitor TCF1 + T-cells correlate with COVID-19 disease severity.

Thai Hien Tu, Ami Grunbaum, François Santinon

|Jan 03, 2024

Stuart Schlossman (1935-2023).

Christopher E Rudd

|Aug 03, 2023

CD8<sup>+</sup> T cell killing of MHC class I-deficient tumors.

Christopher E Rudd

Pageof 2

Frequent Collaborators

Nicholas Rozza

Chen Liu

Yiwei Xiong

Yulan Yi

Naiqi Yang

Mark E Issa

Fatima Ezzahra Bennani

Frequent Collaborators

Nicholas Rozza

Chen Liu

Yiwei Xiong

Yulan Yi